NLRP3 and myocardial infarction: In our current study, we assessed inflammasome inhibition in vitro and hypothesized that NLRP3-inflammasome inhibition with IZD334 reduces IS and preserves cardiac function after MI by reducing post-MI NLRP3-mediated inflammation [17].